Exclusive

Publication

Byline

Location

US Patent Issued on Sept. 1 for "Enriched mineral pitch resin products and methods of manufacturing enriched mineral pitch resin products" (California Inventor)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,876, issued on Sept. 1. "Enriched mineral pitch resin products and methods of manufacturing enriched mineral pitch resin products" was inve... Read More


US Patent Issued on Sept. 1 for "Pharmaceutical composition for conditioning dampness-heat" (Malaysian Inventor)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,877, issued on Sept. 1. "Pharmaceutical composition for conditioning dampness-heat" was invented by Wei Zhi Ooi (Ampang, Malaysia). Accord... Read More


US Patent Issued to PM-INTERNATIONAL on Sept. 1 for "Powdered food supplement for producing a beverage" (German, Luxembourger Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,878, issued on Sept. 1, was assigned to PM-INTERNATIONAL AG (Schengen, Luxembourg). "Powdered food supplement for producing a beverage" was... Read More


US Patent Issued to Hoffmann-La Roche on Sept. 1 for "Peptide macrocycles against Acinetobacter baumannii" (Swiss, British, German Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,879, issued on Sept. 1, was assigned to Hoffmann-La Roche Inc. (Little Falls, N.J.). "Peptide macrocycles against Acinetobacter baumannii" ... Read More


US Patent Issued to BioAegis Therapeutics on Sept. 1 for "Methods and compositions for treating frailty" (American, Finnish Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,880, issued on Sept. 1, was assigned to BioAegis Therapeutics Inc. (Morristown, N.J.). "Methods and compositions for treating frailty" was ... Read More


US Patent Issued to MUSC Foundation for Research Development on Sept. 1 for "Endostatin peptides for the treatment of tumors, fibrosis and acute lung injury" (South Carolina Inventor)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,881, issued on Sept. 1, was assigned to MUSC Foundation for Research Development (Charleston, S.C.). "Endostatin peptides for the treatment... Read More


US Patent Issued to Synlogic Operating on Sept. 1 for "Enumeration of genetically engineered microorganisms by live cell counting techniques" (Massachusetts Inventor)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,882, issued on Sept. 1, was assigned to Synlogic Operating Co. Inc. (Winchester, Mass.). "Enumeration of genetically engineered microorgani... Read More


US Patent Issued on Sept. 1 for "Antiviral agent for combined therapy of COVID-19 (SARS-CoV-2)" (American, Russian Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,883, issued on Sept. 1. "Antiviral agent for combined therapy of COVID-19 (SARS-CoV-2)" was invented by Alexandre Vasilievich Ivachtchenko ... Read More


US Patent Issued on Sept. 1 for "Production of MHC II/CII complexes" (German, Swedish Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,884, issued on Sept. 1. "Production of MHC II/CII complexes" was invented by Nadine Schneider (Frankfurt am Main, Germany), Bingze Xu (Upps... Read More


US Patent Issued to Intervet on Sept. 1 for "Vaccine against Heamophilus parasuis" (Dutch Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,885, issued on Sept. 1, was assigned to Intervet Inc. (Rahway, N.J.). "Vaccine against Heamophilus parasuis" was invented by Antonius Arnol... Read More